Understanding the Insufficiency of €8.95 for RSV Impfung
How €8.95 Falls Short for RSV Impfung
The increasing discontent among healthcare professionals regarding the reimbursement decisions from the Kassenärztlicher Bundesvereinigung (KBV) and the GKV-Spitzenverband is palpable. The recent increase in the reference value by 3.85 percent to 12.3934 cents only adds to the complexities of the situation.
Understanding the Impact of GOP 01941
The anger expressed by pediatricians revolves around the new service under GOP 01941, which pays only €8.95 according to the current orientation value of 11.9339 cents. This payment structure has been a topic in the “ÄrzteTag” podcast, where Dr. Michael Hubmann sheds light on why more than nothing is still woefully inadequate.
- Background: The Federal Ministry of Health (BMG) initially stated that the payment for RSV prophylaxis with Nirsevimab would be included in the patient flat rate.
- Development: However, since no patient flat rate can be billed for purely preventive services, the BMG instructed the self-administration to create a new service for RSV prophylaxis, leading to the introduction of GOP 01941.
Dr. Hubmann elucidates a business analysis in the podcast, arguing that practices cannot possibly recover their costs with such a low fee. He attempts to explain why, despite the implementation of de-budgeting over a year ago, pediatric practices continue to feel pressured to break even, reiterating the frequent complaints of insufficient time for patient care.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.